Candriam S.C.A. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2023$878,333
+45.9%
5,668
+59.4%
0.01%
+50.0%
Q4 2022$601,869
-85.2%
3,555
-74.7%
0.00%
-85.7%
Q3 2021$4,064,000
-33.2%
14,064
-53.8%
0.03%
-33.3%
Q2 2021$6,082,00030,4700.04%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Conestoga Capital Advisors, LLC 1,291,805$53,532,0002.79%
Ranger Investment Management 919,366$38,099,0002.72%
Monashee Investment Management LLC 100,000$4,144,0001.75%
Lisanti Capital Growth, LLC 49,450$2,049,0001.36%
Pier Capital, LLC 175,565$7,275,0001.26%
SANDLER CAPITAL MANAGEMENT 221,070$9,161,0000.99%
PALISADE CAPITAL MANAGEMENT, LP 630,333$26,121,0000.98%
AWM Investment Company, Inc. 120,000$4,973,0000.88%
Stephens Investment Management Group LLC 857,714$35,544,0000.86%
Summit Creek Advisors LLC 79,066$3,276,0000.68%
View complete list of REPLIGEN CORP shareholders